International incidence rates of invasive cervical cancer before cytological screening.
about
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerIndividual management of cervical cancer in pregnancy.American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.The global burden of women's cancers: a grand challenge in global health.Provider-Identified Barriers to Cervical Cancer Screening and Perceptions Toward Self-Collection of Human Papillomavirus in Southwest Virginia.Advances in cervical screening technology.Effectiveness of a simple rapid human papillomavirus DNA test in rural NigeriaAlternative technologies in cervical cancer screening: a randomised evaluation trial.Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities.Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission modelWorldwide burden of cervical cancer in 2008.Human papillomavirus testing in the prevention of cervical cancerRisk Factors for the presence of anal intraepithelial neoplasia in HIV+ men who have sex with men.The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategiesPrimary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.International variation.Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.Common cancer in a wild animal: the California sea lion (Zalophus californianus) as an emerging model for carcinogenesisComparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia.The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countriesComparison of the Cobas 4800 HPV test and the Seeplex HPV4A ACE with the hybrid capture 2 testSexual and reproductive health and human rights of women living with HIV.Attitudes and knowledge of Georgian physicians regarding cervical cancer prevention, 2010Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens.Incidence of cervical cancer after several negative smear results by age 50: prospective observational study.Cost effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screeningModel for assessing human papillomavirus vaccination strategies.Age-related incidence of cervical cancer supports two aetiological components: a population-based register study.Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia.A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.The cost-effectiveness of screening programs using single and multiple birth cohort simulations: a comparison using a model of cervical cancer.Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable.Claudin-1 as a Biomarker of Cervical Cytology and Histology.One lesion, one virus: individual components of high-grade anal intraepithelial neoplasia in HIV-positive men contain a single HPV type.Trends in epidemiology of cervical cancer in Thrace, Greece.The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany.Ethnic factors in the pathology of the uterine cervix cervical screening: a population at variance with national targets.
P2860
Q24607403-C382C969-A438-4D52-A10C-42A690EF0335Q26771286-0BA0025F-C9E4-4E94-AD36-86362DB4283AQ26828840-215BACC9-8151-4808-B944-3ABF3B83D741Q30241791-B2802106-8A6B-4D98-B629-F261857FE35FQ30276307-663D9019-DB02-4244-8BCD-2FF249481113Q30305552-4117A200-B2D4-419F-809D-118EDC1296CAQ30415760-748A6152-AE83-4987-B98A-8D922681BD79Q33260497-33969FB4-B4C0-4D87-BDCD-10FEF5978C99Q33344903-F68D2BF0-05CB-49A0-83D9-5A33CBF18024Q33488325-53507487-FDFF-4C4F-A96C-9C6FC2DB4548Q34176394-99DF9958-EC4F-466F-BA69-B3BE0C99AA65Q34616083-6D68E0D1-356C-4827-BFC2-AC3E609DD492Q35075652-72DF6700-675B-4875-9F6F-7649546F1C18Q35583144-C4545F32-A3EB-4304-B30E-CDF87CF259F4Q35802505-3C23D6B5-D015-41B7-92E1-84BD70007EF3Q35868021-BFCDBFD9-52E3-424D-BB7C-78CF221329F3Q36050334-86FE470E-9148-4A2E-9D57-5F53B6A93F88Q36086827-7326ABA4-6822-4150-AA03-E08A1460AD4CQ36088032-B645F682-CF9B-4FD4-BDF7-A205CD24F47AQ36118559-2E7C94FD-0BAF-4773-A4A9-B9A3F71333F5Q36311966-0E910F18-2221-4E63-99E5-ADED8785CE64Q36353824-1BF13F11-E62A-4AD1-97EF-CBD193589515Q36540098-AEA14363-17F8-457A-82C5-FF3548B088D7Q36744865-84FE65C7-7D10-4A60-8369-0DBB58E8F117Q36812052-93A2E1C1-6D7C-48D8-96CC-6E791E9014D9Q36813303-096110AB-3742-44E6-8782-2FAB4F4935F8Q37169635-21E35B65-4EEA-44C9-BB20-0636B1CC4F54Q37273434-C4D7F1C6-B94D-4AE2-BB7C-038414F6A738Q37302509-05F654E6-B621-4825-BE1D-E5029E301348Q38411153-2A52FB2A-21E8-4735-8245-18225CA267EDQ38655636-44000215-AADB-4204-93C1-E8DFBCDE17B0Q38739053-989E90ED-D35C-4093-864B-4156E31B9110Q40078152-56AAD364-0633-412B-8275-8587FBDF7FF5Q40483993-EAE09C87-C947-457D-B45C-83781E47F0B2Q40500436-D65A18D9-0F15-49B7-A423-35FA412E8D37Q40954466-D6C2936E-05D2-4710-88C8-5FE9F60D890FQ42242177-704090F7-ED36-4120-AB10-74DD2E92AAE7Q44654462-13204309-0B90-429D-B6E4-8FDBAE2CC83DQ50776970-956ABA03-7D28-4B68-A897-695925D302E0Q54751974-208EC9DD-BE3D-449A-8601-5EA1222EE8F4
P2860
International incidence rates of invasive cervical cancer before cytological screening.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
International incidence rates of invasive cervical cancer before cytological screening.
@en
International incidence rates of invasive cervical cancer before cytological screening.
@nl
type
label
International incidence rates of invasive cervical cancer before cytological screening.
@en
International incidence rates of invasive cervical cancer before cytological screening.
@nl
prefLabel
International incidence rates of invasive cervical cancer before cytological screening.
@en
International incidence rates of invasive cervical cancer before cytological screening.
@nl
P2093
P2860
P1476
International incidence rates of invasive cervical cancer before cytological screening.
@en
P2093
L Gustafsson
R Bergström
P2860
P304
P356
10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#
P577
1997-04-01T00:00:00Z